ZAMBONI, STEFANIA
 Distribuzione geografica
Continente #
NA - Nord America 2.647
AS - Asia 1.362
EU - Europa 1.343
SA - Sud America 203
AF - Africa 28
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.589
Nazione #
US - Stati Uniti d'America 2.591
SG - Singapore 526
PL - Polonia 478
CN - Cina 358
DE - Germania 196
BR - Brasile 172
UA - Ucraina 155
VN - Vietnam 138
HK - Hong Kong 120
FI - Finlandia 100
GB - Regno Unito 78
RU - Federazione Russa 66
FR - Francia 65
IT - Italia 61
TR - Turchia 60
IN - India 46
IE - Irlanda 41
CA - Canada 32
SE - Svezia 24
ID - Indonesia 22
BE - Belgio 20
IQ - Iraq 19
BD - Bangladesh 16
ES - Italia 15
JP - Giappone 13
MX - Messico 13
AT - Austria 9
NL - Olanda 9
ZA - Sudafrica 9
AE - Emirati Arabi Uniti 7
AR - Argentina 7
VE - Venezuela 7
EC - Ecuador 6
IR - Iran 6
AU - Australia 5
CO - Colombia 5
LT - Lituania 5
PK - Pakistan 5
CZ - Repubblica Ceca 4
AZ - Azerbaigian 3
BO - Bolivia 3
DZ - Algeria 3
EG - Egitto 3
JO - Giordania 3
KE - Kenya 3
NP - Nepal 3
PA - Panama 3
PT - Portogallo 3
SA - Arabia Saudita 3
TT - Trinidad e Tobago 3
BB - Barbados 2
CL - Cile 2
ET - Etiopia 2
IL - Israele 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
MA - Marocco 2
MK - Macedonia 2
PH - Filippine 2
RO - Romania 2
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BY - Bielorussia 1
CM - Camerun 1
EE - Estonia 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
JM - Giamaica 1
KH - Cambogia 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MU - Mauritius 1
MY - Malesia 1
NG - Nigeria 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TM - Turkmenistan 1
TN - Tunisia 1
UZ - Uzbekistan 1
Totale 5.589
Città #
Warsaw 477
Ashburn 370
Fairfield 269
Singapore 252
San Jose 131
Beijing 126
Woodbridge 124
Jacksonville 122
Hong Kong 120
Seattle 111
Cambridge 99
Houston 96
The Dalles 91
Wilmington 89
New York 85
Ann Arbor 83
Helsinki 75
Princeton 75
Chandler 74
Los Angeles 66
Munich 61
Dong Ket 50
Istanbul 43
Dublin 41
Council Bluffs 36
Lauterbourg 36
Ho Chi Minh City 33
Shanghai 26
Boardman 24
Turku 23
São Paulo 22
Washington 22
Hanoi 21
Brussels 20
Dallas 20
Des Moines 20
Moscow 18
San Francisco 18
Jakarta 17
Redondo Beach 16
Santa Clara 16
Chicago 14
Nanjing 14
Buffalo 13
London 13
San Diego 13
Falkenstein 12
Montreal 12
San Mateo 12
Atlanta 11
Kocaeli 11
Tokyo 11
Augusta 10
Baghdad 10
Milan 10
Shenyang 10
Denver 9
Manchester 9
Nuremberg 9
Toronto 9
Chennai 8
Dearborn 8
Düsseldorf 8
Jinan 8
Monmouth Junction 8
Orem 8
Phoenix 8
Stockholm 8
Tianjin 8
Bari 7
Boston 7
Da Nang 7
Frankfurt am Main 7
Johannesburg 7
Mexico City 7
Nürnberg 7
Porto Alegre 7
Vienna 7
Ardabil 6
Brescia 6
Nanchang 6
Rio de Janeiro 6
Brooklyn 5
Changsha 5
Haikou 5
Hebei 5
Honolulu 5
Leawood 5
Ankara 4
City of London 4
Guangzhou 4
Guayaquil 4
Jiaxing 4
New Delhi 4
Norwalk 4
Paris 4
Parma 4
Poplar 4
Vancouver 4
Zhengzhou 4
Totale 3.967
Nome #
Biological effect of neoadjuvant androgen-deprivation therapy assessed on specimens from radical prostatectomy: a systematic review 245
Differences in trends in the use of robot-assisted and open radical cystectomy and changes over time in peri-operative outcomes among selected centres in North America and Europe: an international multicentre collaboration 230
Robot-assisted Partial Nephrectomy and Bilateral Pyelolithotomy in Ectopic Pelvic Kidneys 225
The impact of completeness of last transurethral resection of bladder tumors on the outcomes of radical cystectomy 218
How to improve patient selection for neoadjuvant chemotherapy in bladder cancer patients candidate for radical cystectomy and pelvic lymph node dissection 205
Long-term Prognostic Impact of Chromosome Abnormalities in Clear Cell Renal Cell Carcinoma 190
[Differences in morbidity of neobladder versus ileal conduit: a matched pair analysis on 134 patients] 178
Standard vs delayed ligature of the dorsal vascular complex during robot-assisted radical prostatectomy: results from a randomized controlled trial 174
MP34-09 IS A DELAY IN THE TIMING OF RADICAL CYSTECTOMY REALLY DETRIMENTAL? A RETROSPECTIVE STUDY ON A SINGLE CENTRE COHORT 169
Renal Function Impairment Below Safety Limits Correlates With Cancer-specific Mortality in Localized Renal Cell Carcinoma: Results From a Single-center Study 165
Prediction tools in non-muscle invasive bladder cancer 164
VARIATIONS IN RENAL CORTEX VOLUMES BEFORE AND AFTER PARTIAL NEPHRECTOMY: A PILOT STUDY ON 30 CASES 155
Histological variants in non-muscle invasive bladder cancer 154
IS A DELAY IN THE TIMING OF RADICAL CYSTECTOMY REALLY DETRIMENTAL? A RETROSPECTIVE STUDY 138
Changes in body composition and lipid profile in prostate cancer patients without bone metastases given Degarelix treatment: the BLADE prospective cohort study 136
MANAGEMENT AND PROGNOSIS OF POSITIVE SURGICAL MARGINS AFTER RADICAL PROSTATECTOMY: RETROSPECTIVE ANALYSIS OF A CONTEMPORARY COHORT 133
The impact of treatment modality on survival in patients with clinical node-positive bladder cancer: results from a multicenter collaboration 133
OUTCOMES OF A PHASE II I RANDOMIZED CONTROLLED TRIAL COMPARING PREVENTIVE VERSUS DELAYED LIGATION OF DORSAL VASCULAR COMPLEX DURING ROBOT-ASSISTED RADICAL PROSTATECTOMY 131
The effect of perioperative blood transfusion on oncological outcomes in radical cystectomy patients: a narrative review 125
Delaying BCG immunotherapy onset after transurethral resection of non-muscle-invasive bladder cancer is associated with adverse survival outcomes 124
ROBOT-ASSISTED PARTIAL NEPHRECTOMYAND BILATERAL PYELOLYTHOTOMY OF ECTOPIC PELVIC KIDNEYS 121
Incidence and survival outcomes in patients with upper urinary tract urothelial carcinoma diagnosed with variant histology and treated with nephroureterectomy 121
Comparing oncological outcomes of laparoscopic vs open radical nephroureterectomy for the treatment of upper tract urothelial carcinoma: A propensity score-matched analysis 121
Is androgen deprivation therapy protective against SARS-CoV-2 infection and related complications in prostate cancer patients? 118
Adjuvant chemotherapy is ineffective in patients with bladder cancer and variant histology treated with radical cystectomy with curative intent 112
Prognostic role of delay before radical cystectomy: Retrospective analysis of a single-center cohort with 376 patients 111
Restaging Transurethral Resection of Bladder Tumours after BCG Immunotherapy Induction in Patients with T1 Non-Muscle-Invasive Bladder Cancer Might not Be Associated with Oncologic Benefit 109
Single postoperative instillation for non-muscle invasive bladder cancer: Are there still any indication? 108
A thigh urinary fistula following radical prostatectomy and external beam radiation therapy for prostate cancer: a case report 108
CLINICAL RECURRENCE AFTER RADICAL CYSTECTOMY FOR BLADDER CANCER, DEFINING OPTIMAL SURVEILLANCE AFTER SURGERY 107
Effect of Degarelix administration on bone health in prostate cancer patients without bone metastases. The Blade study 101
INCIDENCE AND IMPACT OF HISTOLOGICAL VARIANTS ON SURVIVAL IN CANDIDATES FOR RADICAL CYSTECTOMY: RESULTS FROM A MULTICENTER COLLABORATION 100
Relationship between circulating FSH levels and body composition and bone health in patients with prostate cancer who undergo androgen deprivation therapy: The BLADE study 97
THE IMPACT OF HISTOLOGICAL VARIANTS ON SURVIVAL IN IN UPPER URINARY TRACT UROTHELIAL CARCINOMA PATIENTS TREATED WITH NEPHROURETERECTOMY: A MULTICENTER COLLABORATION 94
Whole-body Diffusion-weighted Magnetic Resonance Imaging for Assessment of the Bone Response Rate in Patients with Metastatic Hormone-sensitive Prostate Cancer Receiving Enzalutamide 83
COMPARATIVE EFFECTIVENESS OF ROBOTIC ASSISTED AND OPEN RADICAL CYSTECTOMYIN CONTEMPORARY COHORTS OF BLADDER CANCER PATIENTS: AN INTERNATIONAL MULTICENTER COLLABORATION 82
Accuracy of Transurethral Resection of the Bladder in Detecting Variant Histology of Bladder Cancer Compared with Radical Cystectomy 82
Assessment of the oncological outcomes of three different bacillus Calmette–Guérin strains in patients with high-grade T1 non-muscle-invasive bladder cancer 79
THE IMPACT OF TREATMENT MODALITY ON SURVIVAL IN PATIENTS WITH CLINICAL NODE POSITIVE BLADDER CANCER 74
Heterogeneity in regional changes in body composition induced by androgen deprivation therapy in prostate cancer patients: potential impact on bone health-the BLADE study 72
Precision medicine in localized bladder cancer: Personalizing therapies to improve outcomes 63
THE NECESSITY OF A SECOND TRANSURETHRAL RESECTION FOR PATIENTS DIAGNOSED WITH PTAHG TUMOR AT FIRST TUR: A MULTICENTER COLLABORATION OF EAU YOUNG ACADEMIC UROLOGISTS UROTHELIAL CARCINOMA GROUP 55
Metastasis Within Three Years from Radical Nephroureterectomy as a Potential Surrogate for Overall Survival 52
Addition of zoledronic acid to enzalutamide and androgen deprivation therapy in metastatic hormone-sensitive prostate cancer: the randomized phase II BONENZA trial 43
Total and Regional Changes in Body Composition in Metastatic Hormone-sensitive Prostate Cancer Patients Randomized to Receive Androgen Deprivation + Enzalutamide ± Zoledronic Acid. The BONENZA Study 37
null 13
Totale 5.655
Categoria #
all - tutte 26.390
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.390


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021294 0 0 0 0 0 0 0 0 0 121 91 82
2021/2022327 31 57 5 13 11 23 5 26 16 33 22 85
2022/2023264 40 5 7 19 20 62 2 28 45 0 24 12
2023/2024489 22 6 34 54 29 133 7 40 67 12 5 80
2024/2025869 10 5 3 123 76 72 84 43 122 56 160 115
2025/20261.742 186 189 109 280 245 169 277 64 92 131 0 0
Totale 5.655